UCB (EBR:UCB) UCB Media Room - Disposal of own shares
Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires
19/08/2022 20:00
https://mb.cision.com/Public/18595/3616957/adbb5f604d9e5da8_800x800ar.png
** Disposal of own shares
------------------------------------------------------------
Brussels (Belgium), 19 August 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regulat=
ed information
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following exercises o=
f stock options by members of its personnel, it has disposed of UCB shares =
OTC in view of deliveries of these shares to the relevant members of the pe=
rsonnel, within the framework of the Long-Term Incentive Program of the UCB=
Group, as follows:
https://mb.cision.com/Public/18595/3616957/8a12b25f7b7aec32_800x800ar.png
This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link. (https://www.ucb.com/stories-media/Press-Releases)
For further information, contact UCB:
Investor Relations
Antje Witte
T +32 2 559 94 14
antje.witte@ucb.com (mailto:antje.witte@ucb.com)
Corporate Communications
Laurent Schots
T +32 2 559 92 64
laurent.schots@ucb.com (mailto:laurent.schots@ucb.com) =C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
Image
Disposal of own shares 16 August 2022 (https://mb.cision.com/Public/18595/3=
616957/8a12b25f7b7aec32_org.png) GenericFile
220819 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/36=
16957/92b20415372df8de.pdf) GenericFile
220819 - Alie nation d actions propres FR (https://mb.cision.com/Public/185=
95/3616957/a5ab466b393735c4.pdf) GenericFile
220819 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1=
8595/3616957/afb5f790ff7599b5.pdf)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x113828x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01